<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Biochem Nutr</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Biochem Nutr</journal-id><journal-id journal-id-type="pmc-domain-id">548</journal-id><journal-id journal-id-type="pmc-domain">jcbn</journal-id><journal-id journal-id-type="publisher-id">JCBN</journal-id><journal-title-group><journal-title>Journal of Clinical Biochemistry and Nutrition</journal-title></journal-title-group><issn pub-type="ppub">0912-0009</issn><issn pub-type="epub">1880-5086</issn><issn-l>0912-0009</issn-l><publisher><publisher-name>The Society for Free Radical Research Japan</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10209597</article-id><article-id pub-id-type="pmcid-ver">PMC10209597.1</article-id><article-id pub-id-type="pmcaid">10209597</article-id><article-id pub-id-type="pmcaiid">10209597</article-id><article-id pub-id-type="pmid">37251967</article-id><article-id pub-id-type="doi">10.3164/jcbn.22-144</article-id><article-id pub-id-type="publisher-id">DN/JST.JSTAGE/jcbn/22-144</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Assessment of exposure and DNA damage from second-hand smoke using potential biomarker in urine: cigarettes and heated tobacco products</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kawasaki</surname><given-names initials="Y">Yuya</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="YS">Yun-Shan</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ootsuyama</surname><given-names initials="Y">Yuko</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fujisawa</surname><given-names initials="K">Koichi</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Omori</surname><given-names initials="H">Hisamitsu</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Onoue</surname><given-names initials="A">Ayumi</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kubota</surname><given-names initials="K">Kenichi</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yoshino</surname><given-names initials="T">Toshimi</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nonami</surname><given-names initials="Y">Yoshio</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yoshida</surname><given-names initials="M">Minoru</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yamato</surname><given-names initials="H">Hiroshi</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kawai</surname><given-names initials="K">Kazuaki</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff5" ref-type="aff">5</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><aff id="aff1">
<label>1</label>
<institution>Department of Environmental Oncology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan</institution>, <addr-line>1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555, Japan</addr-line></aff><aff id="aff2">
<label>2</label>
<institution>Department of Biomedical Laboratory Sciences, Faculty of Life Sciences, Kumamoto University</institution>, <addr-line>4-24-1 Kuhonji, Chuo-ku, Kumamoto 862-0976, Japan</addr-line></aff><aff id="aff3">
<label>3</label>
<institution>Department of Internal Medicine, Japanese Red Cross Kumamoto Health Care Center</institution>, <addr-line>2-1-1 Nagamineminami, Higashi-ku, Kumamoto 861-8528, Japan</addr-line></aff><aff id="aff4">
<label>4</label>
<institution>Department of Health Development, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan</institution>, <addr-line>1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555, Japan</addr-line></aff><aff id="aff5">
<label>5</label>
<institution>Center for Stress-related Disease Control and Prevention, University of Occupational and Environmental Health, Japan</institution>, <addr-line>1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555, Japan</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>To whom correspondence should be addressed.&#8195;E-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="kkawai@med.uoeh-u.ac.jp">kkawai@med.uoeh-u.ac.jp</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>18</day><month>3</month><year>2023</year></pub-date><volume>72</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">436526</issue-id><fpage>242</fpage><lpage>247</lpage><history><date date-type="received"><day>26</day><month>12</month><year>2022</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>26</day><month>05</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-05-30 14:25:09.650"><day>30</day><month>05</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 JCBN</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jcbn22-144.pdf"/><abstract><p>Second-hand smoke exposure is an established cause of several adverse health effects. Tobacco smoke exposure in the environment has been improved by the WHO Framework Convention on Tobacco Control. However, concerns have been raised regarding the health effects of heated tobacco products. Analysis of tobacco smoke biomarkers is critical for assessing the health effects of second-hand tobacco smoke exposure. In this study, nicotine metabolites (nicotine, cotinine, <italic toggle="yes">trans</italic>-3'-hydroxycotinine) and carcinogenic 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol were analysed in the urine of non-smokers with or without passive exposure to cigarettes and heated tobacco products. In addition, 7-methylguanine and 8-hydroxy-2'-deoxyguanosine were simultaneously measured as DNA damage markers. The results revealed higher levels of urinary nicotine metabolites and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in participants exposed to second-hand tobacco smoke (both cigarettes and heated tobacco products) at home. In addition, the urinary levels of 7-methylguanine and 8-hydroxy-2'-deoxyguanosine tended to be higher in the second-hand tobacco smoke-exposed group. The urinary levels of nicotine metabolites and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol were high in workplaces with no protection against passive smoking. These biomarkers will be useful for evaluating passive exposure to tobacco products.</p></abstract><kwd-group kwd-group-type="author"><kwd>second-hand smoke</kwd><kwd>passive exposure of tobacco products</kwd><kwd>heated tobacco products</kwd><kwd>urinary biomarker</kwd><kwd>DNA damage</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="1"><title>Introduction</title><p id="p001">Exposure to second-hand smoke (SHS) has been established as a cause of adverse health effects, resulting in 1.2 million deaths annually.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> Tobacco and tobacco smoke contain more than 9,500 chemicals, including 83 carcinogens.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> The International Agency for Research on Cancer classified SHS as a Group 1 human carcinogen.<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup> As a result of a meta-analysis in Japan, SHS exposure at home has been implicated in the statistically significant increase in the risk of lung cancer.<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> Additionally, the revised Health Promotion Act, which requires all workplaces to eliminate SHS by introducing smoke-free spaces inside the building or implementing designated smoking rooms came into effect in 2020 in Japan. In general, precisely evaluating exposure to passive smoking is challenging. Some studies have used urinary cotinine as a marker of SHS,<sup>(<xref rid="B6" ref-type="bibr">6</xref>)</sup> as most of the nicotine absorbed into the body is metabolised to cotinine, the major metabolite of <italic toggle="yes">CYP2A6</italic>.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> Because of the relatively long physical half-life of cotinine (approximately 17&#8197;h), it remains in the blood for a long time and reaches high concentrations in the blood and urine. However, cotinine is further metabolised to <italic toggle="yes">trans</italic>-3'-hydroxycotinine (3-HC) by <italic toggle="yes">CYP2A6</italic>. In addition, inter-individual differences in nicotine metabolism have been observed due to <italic toggle="yes">CYP2A6</italic> genetic polymorphisms. Uridine 5'-diphospho-glucuronosyltransferase-catalysed <italic toggle="yes">N</italic>-glucuronidation is well known as a metabolic pathway of nicotine, cotinine, and 3-HC.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup> Therefore, in this study, we performed enzymatic hydrolysis of glucuronide conjugates prior to urine sample analysis. To evaluate the total nicotine metabolites as biomarkers of passive smoking, the total nicotine equivalents (TNE; nicotine, cotinine, 3-HC, and glucuronide conjugates) were determined in parallel. Furthermore, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and NNAL-glucuronides are metabolites of tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK),<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup> and NNK and NNAL are potent carcinogens. Urinary NNAL levels (the sum of NNAL and NNAL glucuronides) have been evaluated in both smokers and second-hand smokers.<sup>(<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>)</sup> Urinary NNAL has a relatively longer half-life (10&#8211;21 days) than urinary cotinine (17&#8197;h) and can be detected even a few weeks after tobacco smoke exposure.<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> Total NNAL and NNAL-glucuronides are expected to be a potential biomarker for estimating environmental tobacco exposure. In this study, nicotine-related metabolites, as well as the tobacco smoke-specific carcinogenic metabolite, NNAL was measured.</p><p id="p002">In addition to tobacco smoke exposure markers, health effect markers at a relatively early stage (DNA methyl adducts and oxidative DNA damage) were determined. Methane diazonium ions, metabolic intermediates of NNAL and NNK, react with DNA to form methyl adducts, such as 7-methylguanine (m<sup>7</sup>Gua) and O<sup>6</sup>-methylguanine.<sup>(<xref rid="B13" ref-type="bibr">13</xref>)</sup> In fact, m<sup>7</sup>Gua has been detected in the tissues of animals treated with NNK, and higher levels of m<sup>7</sup>Gua have been detected in the lung DNA of current smokers.<sup>(<xref rid="B14" ref-type="bibr">14</xref>)</sup> Moreover, m<sup>7</sup>Gua in the DNA is excreted into the urine by base excision repair and spontaneous depurination.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup> We focused on urinary m<sup>7</sup>Gua levels as a biomarker of passive smoking. Tobacco smoke contains toxic, carcinogenic, and mutagenic chemicals, as well as free radicals and reactive oxygen species. These highly reactive substances react with DNA to induce oxidative damage. The levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG) or 8-hydroxygunine, the most widely used biomarkers of oxidative stress,<sup>(<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>)</sup> have been previously determined in the urine,<sup>(<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>)</sup> blood,<sup>(<xref rid="B20" ref-type="bibr">20</xref>)</sup> and saliva of cigarette smokers.<sup>(<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>)</sup> However, urinary m<sup>7</sup>Gua and 8-OHdG levels may also be useful early health markers of tobacco smoke exposure.</p><p id="p003">Individuals can be exposed to SHS in their homes, workplaces, and public places. For example, the Centers for Disease Control and Prevention in the United States reported that 19.9% of non-smokers experienced some degree of smoke exposure on the job.<sup>(<xref rid="B23" ref-type="bibr">23</xref>)</sup> According to the National Health and Nutrition Survey in Japan in 2019,<sup>(<xref rid="B24" ref-type="bibr">24</xref>)</sup> individuals could be exposed to passive smoking in the workplace (16.0%), at home (12.5%), on the road (24.1%), and in restaurants (20.8%). The National Institute for Occupational Safety and Health has also determined SHS to be an occupational carcinogen.<sup>(<xref rid="B25" ref-type="bibr">25</xref>)</sup> Therefore, in this study we evaluated passive smoking at home and in the workplace.</p><p id="p004">The use of heated tobacco products (HTPs) has recently increased. According to the WHO, all forms of tobacco smoking, including HTPs, are harmful.<sup>(<xref rid="B26" ref-type="bibr">26</xref>)</sup> Moreover, the European Respiratory Society concluded that, as with cigarette smoking, HTPs are addictive and carcinogenic to humans.<sup>(<xref rid="B27" ref-type="bibr">27</xref>)</sup> While HTPs are less toxic than conventional cigarettes at 5% dilution, they are cytotoxic to cultured cells.<sup>(<xref rid="B28" ref-type="bibr">28</xref>)</sup> Currently, few studies have reported on the biological monitoring of second-hand exposure to HTPs.<sup>(<xref rid="B29" ref-type="bibr">29</xref>)</sup> Therefore, we also evaluated second-hand exposure to HTPs at home using urinary biomarkers.</p></sec><sec sec-type="1"><title>Materials and Methods</title><sec sec-type="2"><title>Urine samples</title><p id="p005">A total of 746 non-smoking volunteers participated in 2019 and 2021 at the time of periodic medical examinations at the Japanese Red Cross Kumamoto Health Care Center. Urine samples were collected in 5-ml polypropylene tubes and stored at &#8722;30&#176;C until analysis. Information regarding smoking status was obtained from the lifestyle questionnaire completed at the time of urine collection. The questionnaire for SHS exposure in the workplace was conducted only in 2021. The number of people analysed [number of subjects, median age (minimum&#8211;maximum)] was as follows based on the questionnaire results for each analysis: analysis of passive smokers at home: male [283, 51 (23&#8211;83)]; female [393, 51 (19&#8211;83)]; analysis of passive smokers at the workplace (countermeasure against SHS): male [181, 50 (23&#8211;74)]; female [277, 50 (25&#8211;74)]; analysis of passive smokers in the workplace (exposure frequency): male [185, 50 (23&#8211;83)]; female [288, 51 (25&#8211;75)]. This study was approved by the University of Occupational and Environmental Health, Japan Ethics Committee (R1-037) and Kumamoto University Ethics Committee (1753).</p></sec><sec sec-type="2"><title>Analysis of tobacco exposure biomarkers</title><p id="p006">We determined the urinary nicotine, cotinine, 3-HC, and NNAL levels by LC-MS/MS according to the method described by Kawasaki <italic toggle="yes">et al.</italic><sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup></p></sec><sec sec-type="2"><title>Analysis of DNA damage biomarkers</title><p id="p007">Urinary m<sup>7</sup>Gua and 8-OHdG concentrations were determined using a previously described method employing HPLC-UV/ECD.<sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup></p></sec><sec sec-type="2"><title>Statistical methods</title><p id="p008">The values for each biomarker were compared using the median values because the data did not follow a normal distribution. Analysis of variance and multiple comparisons were performed using GraphPad Prism, ver. 9.31 (GraphPad Software, San Diego, CA). Two-sided <italic toggle="yes">p</italic> values &lt;0.05 were considered significant.</p></sec></sec><sec sec-type="1"><title>Results</title><sec sec-type="2"><title>Urinary biomarker levels of passive smokers at the home</title><p id="p009">The urinary levels of nicotine and its metabolites (cotinine, 3-HC, and TNE) were significantly higher in non-smokers with passive exposure to tobacco products, regardless of the type of tobacco (cigarettes or HTPs) (<xref rid="T1" ref-type="table">Table&#8197;1</xref>). The urinary nicotine levels were 1.5 and 1.4 times higher in non-smokers with passive exposure to cigarettes and HTPs than those without passive exposure to cigarettes and HTPs, respectively. Urinary cotinine levels were approximately 2.4 times higher and urinary 3-HC levels were approximately 3 to 2 times higher in non-smokers with passive exposure to cigarettes and HTPs, respectively. As a biomarker of total tobacco smoke exposure, the urinary TNE levels were approximately twice as high in the passive inhalation of cigarette and HTPs smoke group than in the no inhalation group. Urinary NNAL levels were approximately 1.5 times higher in participants with passive exposure to cigarette and HTPs smoke. The m<sup>7</sup>Gua levels, as a marker of adverse health effects, were also high in the group with passive exposure to cigarette and HTPs smoke. However, urinary 8-OHdG levels were almost the same in each group. Although the number of subjects was limited, the levels of urinary nicotine metabolites, NNAL, m<sup>7</sup>Gua, and 8-OHdG tended to be high after dual passive exposure to both cigarettes and HTPs.</p></sec><sec sec-type="2"><title>Urinary biomarker levels of passive smokers at the workplace</title><p id="p010">In 2021, a question regarding countermeasures against SHS in the workplace was added to the survey. The results showed that the urinary TNE levels were significantly lower in workplaces with countermeasures against SHS (i.e., no smoking inside the building or a designated smoking room) (<xref rid="T2" ref-type="table">Table&#8197;2</xref>). The urinary NNAL levels, a metabolite of carcinogenic compounds derived from smoking, were significantly higher in the absence of countermeasures against SHS. Finally, the urinary TNE levels were significantly higher in the daily exposure group than in the non-exposure group (<xref rid="T3" ref-type="table">Table&#8197;3</xref>).</p></sec><sec sec-type="2"><title>Relationship between nicotine metabolites and NNAL, m<sup>7</sup>Gua, and 8-OHdG in urine</title><p id="p011">The total NNAL levels in non-smokers were positively correlated with TNE in urine (<italic toggle="yes">p</italic>&lt;0.01) (<xref rid="F1" ref-type="fig">Fig.&#8197;1</xref>). Urinary m<sup>7</sup>Gua and 8-OHdG levels showed a weak positive correlation with TNE levels in urine (<italic toggle="yes">p</italic>&lt;0.05).</p></sec></sec><sec sec-type="1"><title>Discussion</title><p id="p012">Nicotine metabolites (nicotine, cotinine, 3-hydroxycotinine, and TNE) in urine have been measured as biomarkers of SHS exposure. NNAL has recently been used as a biomarker of SHS exposure for non-smokers based on the progress of analytical methods. A major advantage of measuring NNAL is that NNAL and its glucuronides (NNAL-Gluc) are carcinogenic urinary metabolites of the tobacco-specific lung carcinogen, NNK. Currently, most reports on SHS biomonitoring have targeted cigarette smoke exposure. In this study, urinary biomarker levels were significantly higher in non-smokers with passive exposure to cigarette smoke, which is consistent with the results of previous reports. However, despite the increasing number of HTP users, few studies have evaluated the urinary biomarkers of passive exposure to HTPs. Higher levels of total nicotine metabolites (cotinine and 3-HC) have been reported in the spouses and children of fathers who use HTPs.<sup>(<xref rid="B29" ref-type="bibr">29</xref>)</sup> This study showed that the urinary levels of TNE from exposure to cigarettes and HTPs were in the same range. Moreover, the concentration of nicotine in the tobacco filters and mainstream smoke of HTPs was nearly the same as that of cigarettes.<sup>(<xref rid="B30" ref-type="bibr">30</xref>)</sup> The urinary TNE levels observed in this study were reasonable. Thus, even if a smoker switches from cigarettes to HTPs for health reasons, the adverse health effects derived from nicotine on the non-smoking family members will not change significantly.</p><p id="p013">Regarding NNAL, the concentration in HTP sticks has been found to be one-fifth that of cigarettes.<sup>(<xref rid="B30" ref-type="bibr">30</xref>)</sup> However, in this study, the urinary TNE levels of the HTP-exposed group were in the same range as those in the cigarette smoke-exposed group. Although the reason for this is unclear, the long half-life of urinary NNAL may have affected this outcome. Urinary NNAL levels can accumulate and remain at a certain concentration even after intermittent exposure to passive smoking. Although the number of dual smokers was limited, the median levels of each biomarker were high, and the 25% quartile levels were similar to those of cigarette or HTPs smokers. This may have included heavy smokers in the dual smoker group.</p><p id="p014">The urinary concentration of total NNAL is positively associated with urinary m<sup>7</sup>Gua levels in smokers.<sup>(<xref rid="B31" ref-type="bibr">31</xref>)</sup> The urinary levels of m<sup>7</sup>Gua were significantly positively correlated with cigarettes smoked per day and the Brinkman index.<sup>(<xref rid="B32" ref-type="bibr">32</xref>)</sup> Similarly, the urinary m<sup>7</sup>Gua levels have been shown to be higher in cigarettes smokers.<sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup> Moreover, m<sup>7</sup>Gua levels decreased with smoking cessation.<sup>(<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B34" ref-type="bibr">34</xref>)</sup> In this study, significantly high levels of urinary m<sup>7</sup>Gua were observed in non-smokers with passive exposure to cigarettes and/or HTPs. This result indicates that passive exposure to HTPs may cause adverse health effects in non-smokers.</p><p id="p015">Increased levels of 8-OHdG in the lungs and white blood cells of smokers compared with non-smokers have been reported.<sup>(<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B35" ref-type="bibr">35</xref>)</sup> Similarly, 8-OHdG levels in the urine and 8-hydroxyguanine levels in the saliva were found to be significantly higher in smokers.<sup>(<xref rid="B22" ref-type="bibr">22</xref>)</sup> This could be because cigarette smoke contains high levels of free radicals,<sup>(<xref rid="B36" ref-type="bibr">36</xref>)</sup> which can produce oxidative DNA damage, typified by 8-OHdG. Likewise, in a previous study, NNK treatment increased 8-OHdG levels in mouse and rat DNA,<sup>(<xref rid="B37" ref-type="bibr">37</xref>)</sup> which may have resulted from hydroxyl radicals or other reactive oxygen species generated during NNK metabolism. Moreover, SHS-exposed subjects exhibited higher 8-OHdG levels in the DNA of leukocytes,<sup>(<xref rid="B38" ref-type="bibr">38</xref>)</sup> and in another study, the level of urinary 8-OHdG tended to be higher in the SHS-exposed group.<sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup> In this study, urinary 8-OHdG levels were not significantly different between those exposed and non-exposed to cigarettes or HTPs, which could be explained by the discrepancy between self-reported smokers and non-smokers in this study. In fact, the analysis of all participants showed a statistically positive relationship between TNE and 8-OHdG. Although 8-OHdG is not a specific marker of tobacco smoke exposure, it could be useful for evaluating the adverse health effects of SHS.</p><p id="p016">At the workplace, urinary TNE and NNAL levels of non-smokers were significantly low due to the anti-smoking measures. Designated smoking rooms are ineffective in protecting against exposure to tobacco smoke, and little difference was observed between the effects of a smoke-free building and designated smoking rooms. Additionally, despite the prohibition of smoking inside buildings, SHS exposure may occur around the building. Thus, a complete ban on smoking may be effective in reducing SHS exposure.</p><p id="p017">To our knowledge, this is the first study to evaluate NNAL, m<sup>7</sup>Gua, and 8-OHdG levels in urine as biomarkers of adverse health effects in passive smokers of HTPs. While cotinine is the gold-standard biomarker of tobacco exposure, the simultaneous determination of urinary TNE and other biomarkers, such as NNAL, m<sup>7</sup>Gua, and 8-OHdG, enables a better evaluation of SHS exposure.</p></sec><sec sec-type="1"><title>Author Contributions</title><p id="p018">KKawai, YK, HO, KF, and HY designed and critically discussed the study. HO, AO, KKubota, TY, YN, and MY collected the samples and questionnaires. YK and KKawai analysed the nicotine, cotinine, 3-HC, and NNAL content in the urine. Y-SL and YO analysed the 8-OHdG and m<sup>7</sup>Gua content in the urine. YK and KKawai statistically analysed the data. All authors have read and approved the final manuscript.</p></sec></body><back><ack><title>Acknowledgments</title><p id="p019">This work was supported by the Ministry of Health, Labour and Welfare Sciences Research Grants, Comprehensive Research on Lifestyle Related Diseases including Cardiovascular Diseases and Diabetes Mellitus, Program Grant Number JPMH 20FA1020. We thank Ms. Megumi Taketomi for her assistance with the sample preparation for the measurement of urinary biomarkers.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>3-HC</term><def><p><italic toggle="yes">trans</italic>-3'-hydroxycotinine</p></def></def-item><def-item><term>HTPs</term><def><p>heated tobacco products</p></def></def-item><def-item><term>m<sup>7</sup>Gua</term><def><p>7-methylguanine</p></def></def-item><def-item><term>NNAL</term><def><p>4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol</p></def></def-item><def-item><term>NNK</term><def><p>4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone</p></def></def-item><def-item><term>8-OHdG</term><def><p>8-hydroxy-2'-deoxyguanosine</p></def></def-item><def-item><term>SHS</term><def><p>second-hand smoke</p></def></def-item><def-item><term>TNE</term><def><p>total nicotine equivalents</p></def></def-item></def-list></glossary><sec sec-type="COI-statement"><title>Conflict of Interest</title><p id="p020">No potential conflicts of interest were disclosed.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="webpage" publication-format="online">Tobacco. World Health Organization. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/health-topics/tobacco#tab=tab_1">https://www.who.int/health-topics/tobacco#tab=tab_1</uri>. Accessed 12 Dec 2022.</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Hecht</surname><given-names>SS</given-names></string-name></person-group>. <article-title>Carcinogenic components of tobacco and tobacco smoke: a 2022 update</article-title>. <source>Food Chem Toxicol</source><year>2022</year>; <volume>165</volume>: <fpage>113179</fpage>.<pub-id pub-id-type="pmid">35643228</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fct.2022.113179</pub-id><pub-id pub-id-type="pmcid">PMC9616535</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>IARC Working Group on the Evaluation of Carcinogenic Risks to</surname><given-names>Humans</given-names></string-name></person-group>. <article-title>Tobacco smoke and involuntary smoking</article-title>. <source>IARC Monogr Eval Carcinog Risks Hum</source><year>2004</year>; <volume>83</volume>: <fpage>1</fpage>&#8211;<lpage>1438</lpage>.<pub-id pub-id-type="pmid">15285078</pub-id><pub-id pub-id-type="pmcid">PMC4781536</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>IARC Working Group on the Evaluation of Carcinogenic Risks to</surname><given-names>Humans</given-names></string-name></person-group>. <article-title>Personal habits and indoor combustions</article-title>. <source>IARC Monogr Eval Carcinog Risks Hum</source><year>2012</year>; <volume>100 (Pt E)</volume>: <fpage>43</fpage>&#8211;<lpage>211</lpage>.<pub-id pub-id-type="pmcid">PMC4781577</pub-id><pub-id pub-id-type="pmid">23193840</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Hori</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tanaka</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wakai</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Sasazuki</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Katanoda</surname><given-names>K</given-names></string-name></person-group>. <article-title>Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies</article-title>. <source>Jpn J Clin Oncol</source><year>2016</year>; <volume>46</volume>: <fpage>942</fpage>&#8211;<lpage>951</lpage>.<pub-id pub-id-type="pmid">27511987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jjco/hyw091</pub-id><pub-id pub-id-type="pmcid">PMC5063005</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Avila-Tang</surname><given-names>E</given-names></name><name name-style="western"><surname>Elf</surname><given-names>JL</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Assessing secondhand smoke exposure with reported measures</article-title>. <source>Tob Control</source><year>2013</year>; <volume>22</volume>: <fpage>156</fpage>&#8211;<lpage>163</lpage>.<pub-id pub-id-type="pmid">22949496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tobaccocontrol-2011-050296</pub-id><pub-id pub-id-type="pmcid">PMC3639349</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Nakajima</surname><given-names>M</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>JT</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>N</given-names></name><etal/></person-group><article-title>Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans</article-title>. <source>Clin Pharmacol Ther</source><year>2001</year>; <volume>69</volume>: <fpage>72</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="pmid">11180041</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mcp.2001.112688</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Murphy</surname><given-names>SE</given-names></string-name></person-group>. <article-title>Biochemistry of nicotine metabolism and its relevance to lung cancer</article-title>. <source>J Biol Chem</source><year>2021</year>; <volume>296</volume>: <fpage>100722</fpage>.<pub-id pub-id-type="pmid">33932402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbc.2021.100722</pub-id><pub-id pub-id-type="pmcid">PMC8167289</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>IARC Working Group on the Evaluation of Carcinogenic Risks to</surname><given-names>Humans</given-names></string-name></person-group>. <article-title>Smokeless tobacco and some tobacco-specific <italic toggle="yes">N</italic>-nitrosamines</article-title>. <source>IARC Monogr Eval Carcinog Risks Hum</source><year>2007</year>; <volume>89</volume>: <fpage>1</fpage>&#8211;<lpage>626</lpage>.<pub-id pub-id-type="pmid">18335640</pub-id><pub-id pub-id-type="pmcid">PMC4781254</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Hecht</surname><given-names>SS</given-names></string-name></person-group>. <article-title>Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke</article-title>. <source>Tob Control</source><year>2004</year>; <volume>13 Suppl 1</volume>: <fpage>i48</fpage>&#8211;<lpage>i56</lpage>.<pub-id pub-id-type="pmid">14985617</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tc.2002.002816</pub-id><pub-id pub-id-type="pmcid">PMC1766147</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Kawasaki</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>YS</given-names></string-name>, <string-name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ootsuyama</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kawai</surname><given-names>K</given-names></string-name></person-group>. <article-title>Urinary biomarkers for secondhand smoke and heated tobacco products exposure</article-title>. <source>J Clin Biochem Nutr</source><year>2021</year>; <volume>69</volume>: <fpage>37</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="pmid">34376912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3164/jcbn.20-183</pub-id><pub-id pub-id-type="pmcid">PMC8325761</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Benowitz</surname><given-names>NL</given-names></name><name name-style="western"><surname>Bernert</surname><given-names>JT</given-names></name><name name-style="western"><surname>Foulds</surname><given-names>J</given-names></name><etal/></person-group><article-title>Biochemical verification of tobacco use and abstinence: 2019 update</article-title>. <source>Nicotine Tob Res</source><year>2020</year>; <volume>22</volume>: <fpage>1086</fpage>&#8211;<lpage>1097</lpage>.<pub-id pub-id-type="pmid">31570931</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntz132</pub-id><pub-id pub-id-type="pmcid">PMC7882145</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Hecht</surname><given-names>SS</given-names></string-name></person-group>. <article-title>DNA adduct formation from tobacco-specific <italic toggle="yes">N</italic>-nitrosamines</article-title>. <source>Mutat Res</source><year>1999</year>; <volume>424</volume>: <fpage>127</fpage>&#8211;<lpage>142</lpage>.<pub-id pub-id-type="pmid">10064856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0027-5107(99)00014-7</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Crosbie</surname><given-names>PA</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>K</given-names></name><name name-style="western"><surname>Shah</surname><given-names>R</given-names></name><etal/></person-group><article-title>Topographical study of <italic toggle="yes">O</italic><sup>6</sup>-alkylguanine DNA alkyltransferase repair activity and N7-methylguanine levels in resected lung tissue</article-title>. <source>Chem Biol Interact</source><year>2013</year>; <volume>204</volume>: <fpage>98</fpage>&#8211;<lpage>104</lpage>.<pub-id pub-id-type="pmid">23665414</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2013.04.013</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Loft</surname><given-names>S</given-names></name><name name-style="western"><surname>Svoboda</surname><given-names>P</given-names></name><name name-style="western"><surname>Kasai</surname><given-names>H</given-names></name><etal/></person-group><article-title>Prospective study of urinary excretion of 7-methylguanine and the risk of lung cancer: effect modification by mu class glutathione-S-transferases</article-title>. <source>Int J Cancer</source><year>2007</year>; <volume>121</volume>: <fpage>1579</fpage>&#8211;<lpage>1584</lpage>.<pub-id pub-id-type="pmid">17565746</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.22863</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Kasai</surname><given-names>H</given-names></string-name></person-group>. <article-title>Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis</article-title>. <source>Mutat Res</source><year>1997</year>; <volume>387</volume>: <fpage>147</fpage>&#8211;<lpage>163</lpage>.<pub-id pub-id-type="pmid">9439711</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1383-5742(97)00035-5</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="book">Kasai H, Kawai K. 8-Hydroxyguanine, an oxidative DNA and RNA modification. In: Jurga S, Erdmann VA, Barciszewski J, eds. <italic toggle="yes">Modified Nucleic Acids in Biology and Medicine</italic>. Springer International Publishing, 2016; 147&#8211;185.</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Loft</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Vistisen</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ewertz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tj&#248;nneland</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Overvad</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Poulsen</surname><given-names>HE</given-names></string-name></person-group>. <article-title>Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index</article-title>. <source>Carcinogenesis</source><year>1992</year>; <volume>13</volume>: <fpage>2241</fpage>&#8211;<lpage>2247</lpage>.<pub-id pub-id-type="pmid">1473230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/carcin/13.12.2241</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Irie</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tamae</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Iwamoto-Tanaka</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kasai</surname><given-names>H</given-names></string-name></person-group>. <article-title>Occupational and lifestyle factors and urinary 8-hydroxydeoxyguanosine</article-title>. <source>Cancer Sci</source><year>2005</year>; <volume>96</volume>: <fpage>600</fpage>&#8211;<lpage>606</lpage>.<pub-id pub-id-type="pmid">16128745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1349-7006.2005.00083.x</pub-id><pub-id pub-id-type="pmcid">PMC11159759</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Asami</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hirano</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Yamaguchi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Tomioka</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Itoh</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kasai</surname><given-names>H</given-names></string-name></person-group>. <article-title>Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking</article-title>. <source>Cancer Res</source><year>1996</year>; <volume>56</volume>: <fpage>2546</fpage>&#8211;<lpage>2549</lpage>.<pub-id pub-id-type="pmid">8653695</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Kawai</surname><given-names>K</given-names></name><name name-style="western"><surname>Kasai</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>YS</given-names></name><etal/></person-group><article-title>Measurement of 8-hydroxyguanine as an oxidative stress biomarker in saliva by HPLC-ECD</article-title>. <source>Genes Environ</source><year>2018</year>; <volume>40</volume>: <fpage>5</fpage>.<pub-id pub-id-type="pmid">29632621</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s41021-018-0095-2</pub-id><pub-id pub-id-type="pmcid">PMC5883350</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kawasaki</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kawai</surname><given-names>K</given-names></string-name></person-group>. <article-title>Salivary 8-hydroxyguanine as a lifestyle-related oxidative stress biomarker in workers</article-title>. <source>J Clin Biochem Nutr</source><year>2020</year>; <volume>66</volume>: <fpage>57</fpage>&#8211;<lpage>61</lpage>.<pub-id pub-id-type="pmid">32001957</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3164/jcbn.19-72</pub-id><pub-id pub-id-type="pmcid">PMC6983431</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Su</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>Syamlal</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Tamers</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Luckhaupt</surname><given-names>SE</given-names></string-name></person-group>. <article-title>Workplace Secondhand Tobacco Smoke Exposure Among U.S. Nonsmoking Workers, 2015</article-title>. <source>MMWR Morb Mortal Wkly Rep</source><year>2019</year>; <volume>68</volume>: <fpage>604</fpage>&#8211;<lpage>607</lpage>.<pub-id pub-id-type="pmid">31295233</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15585/mmwr.mm6827a2</pub-id><pub-id pub-id-type="pmcid">PMC6741854</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="webpage" publication-format="online">The National Health and Nutrition Survey (NHNS) Japan, 2019. The Ministry of Health, Labor and Welfare. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mhlw.go.jp/bunya/kenkou/kenkou_eiyou_chousa.html">https://www.mhlw.go.jp/bunya/kenkou/kenkou_eiyou_chousa.html</uri>. Accessed 12 Dec 2022. (in Japanese)</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="webpage" publication-format="online">Environmental Tobacco Smoke in the Workplace: Lung Cancer and Other Health Effects. The National Institute for Occupational Safety and Health. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/niosh/docs/91-108/default.html">https://www.cdc.gov/niosh/docs/91-108/default.html</uri>. Accessed 12 Dec 2022.</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="webpage" publication-format="online">Heated Tobacco Products: Information Sheet - 2nd Edition. World Health Organization. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/publications/i/item/WHO-HEP-HPR-2020.2">https://www.who.int/publications/i/item/WHO-HEP-HPR-2020.2</uri>. Accessed 12 Dec 2022.</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="webpage" publication-format="online">ERS Position Paper on Heated Tobacco Products. European Respiratory Society. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ersnet.org/news-and-features/news/ers-position-paper-on-heated-tobacco-products/">https://www.ersnet.org/news-and-features/news/ers-position-paper-on-heated-tobacco-products/</uri>. Accessed 12 Dec 2022.</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Lyu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hayashi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sato</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Toyokuni</surname><given-names>S</given-names></string-name></person-group>. <article-title>Diluted aqueous extract of heat-not-burn tobacco product smoke causes less oxidative damage in fibroblasts than conventional cigarette</article-title>. <source>J Clin Biochem Nutr</source><year>2022</year>; <volume>71</volume>: <fpage>55</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="pmid">35903603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3164/jcbn.21-134</pub-id><pub-id pub-id-type="pmcid">PMC9309084</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Onoue</surname><given-names>A</given-names></name><name name-style="western"><surname>Inaba</surname><given-names>Y</given-names></name><name name-style="western"><surname>Machida</surname><given-names>K</given-names></name><etal/></person-group><article-title>Association between fathers&#8217; use of heated tobacco products and urinary cotinine concentrations in their spouses and children</article-title>. <source>Int J Environ Res Public Health</source><year>2022</year>; <volume>19</volume>: <fpage>6275</fpage>.<pub-id pub-id-type="pmid">35627812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijerph19106275</pub-id><pub-id pub-id-type="pmcid">PMC9140953</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Bekki</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Inaba</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Uchiyama</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kunugita</surname><given-names>N</given-names></string-name></person-group>. <article-title>Comparison of chemicals in mainstream smoke in heat-not-burn tobacco and combustion cigarettes</article-title>. <source>J UOEH</source><year>2017</year>; <volume>39</volume>: <fpage>201</fpage>&#8211;<lpage>207</lpage>.<pub-id pub-id-type="pmid">28904270</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7888/juoeh.39.201</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Hu</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>YW</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Tam</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Chao</surname><given-names>MR</given-names></string-name></person-group>. <article-title>Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions</article-title>. <source>Arch Toxicol</source><year>2014</year>; <volume>88</volume>: <fpage>291</fpage>&#8211;<lpage>299</lpage>.<pub-id pub-id-type="pmid">24057573</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-013-1137-y</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Tamae</surname><given-names>K</given-names></name><name name-style="western"><surname>Kawai</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamasaki</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine</article-title>. <source>Cancer Sci</source><year>2009</year>; <volume>100</volume>: <fpage>715</fpage>&#8211;<lpage>721</lpage>.<pub-id pub-id-type="pmid">19469016</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1349-7006.2009.01088.x</pub-id><pub-id pub-id-type="pmcid">PMC11158129</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Ichiba</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Matsumoto</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kondoh</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Horita</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tomokuni</surname><given-names>K</given-names></string-name></person-group>. <article-title>Decreasing urinary PAH metabolites and 7-methylguanine after smoking cessation</article-title>. <source>Int Arch Occup Environ Health</source><year>2006</year>; <volume>79</volume>: <fpage>545</fpage>&#8211;<lpage>549</lpage>.<pub-id pub-id-type="pmid">16404638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00420-005-0071-6</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Kawasaki</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>YS</given-names></string-name>, <string-name name-style="western"><surname>Ootsuyama</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Nagata</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Yamato</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kawai</surname><given-names>K</given-names></string-name></person-group>. <article-title>Effects of smoking cessation on biological monitoring markers in urine</article-title>. <source>Genes Environ</source><year>2020</year>; <volume>42</volume>: <fpage>26</fpage>.<pub-id pub-id-type="pmid">32944094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s41021-020-00165-z</pub-id><pub-id pub-id-type="pmcid">PMC7488543</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Asami</surname><given-names>S</given-names></name><name name-style="western"><surname>Manabe</surname><given-names>H</given-names></name><name name-style="western"><surname>Miyake</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung</article-title>. <source>Carcinogenesis</source><year>1997</year>; <volume>18</volume>: <fpage>1763</fpage>&#8211;<lpage>1766</lpage>.<pub-id pub-id-type="pmid">9328173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/carcin/18.9.1763</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Pryor</surname><given-names>WA</given-names></string-name></person-group>. <article-title>Biological effects of cigarette smoke, wood smoke, and the smoke from plastics: the use of electron spin resonance</article-title>. <source>Free Radic Biol Med</source><year>1992</year>; <volume>13</volume>: <fpage>659</fpage>&#8211;<lpage>676</lpage>.<pub-id pub-id-type="pmid">1334034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0891-5849(92)90040-n</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Chung</surname><given-names>FL</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Increased 8-oxodeoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with the tobacco-specific nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone</article-title>. <source>Carcinogenesis</source><year>1992</year>; <volume>13</volume>: <fpage>1269</fpage>&#8211;<lpage>1272</lpage>.<pub-id pub-id-type="pmid">1638697</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/carcin/13.7.1269</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><string-name name-style="western"><surname>Lodovici</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Caldini</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Luceri</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bambi</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Boddi</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Dolara</surname><given-names>P</given-names></string-name></person-group>. <article-title>Active and passive smoking and lifestyle determinants of 8-oxo-7,8-dihydro-2'-deoxyguanosine levels in human leukocyte DNA</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source><year>2005</year>; <volume>14</volume>: <fpage>2975</fpage>&#8211;<lpage>2977</lpage>.<pub-id pub-id-type="pmid">16365019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1055-9965.EPI-04-0906</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1" orientation="portrait"><label>Fig.&#8196;1.</label><caption><p>Relationship between TNE levels and NNAL, m<sup>7</sup>Gua, and 8-OHdG in the urine of non-smokers.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcbn22-144f01.jpg"/></fig><table-wrap position="float" id="T1" orientation="portrait"><label>Table&#8196;1.</label><caption><p>Urinary biomarker levels of passive exposure of tobacco products among non-smokers at home</p></caption><table frame="hsides" rules="groups"><col width="22" span="1"/><col width="14" span="1"/><col width="16" span="1"/><col width="16" span="1"/><col width="16" span="1"/><col width="16" span="1"/><thead><tr><th align="left" valign="middle" colspan="2" rowspan="1">Type of passive exposure</th><th align="center" valign="middle" rowspan="1" colspan="1">No exposure</th><th align="center" valign="middle" rowspan="1" colspan="1">Cigarettes</th><th align="center" valign="middle" rowspan="1" colspan="1">HTPs</th><th align="center" valign="middle" rowspan="1" colspan="1">Dual</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Number of participants</td><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">562</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td><td align="center" valign="middle" rowspan="1" colspan="1">46</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">Nicotine <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65*</td><td align="center" valign="middle" rowspan="1" colspan="1">0.62**</td><td align="center" valign="middle" rowspan="1" colspan="1">1.10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile<sup>&#167;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">(0.25&#8211;0.72)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.31&#8211;1.10)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.42&#8211;1.30)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.55&#8211;1.80)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.51</td><td align="center" valign="middle" rowspan="1" colspan="1">1.44</td><td align="center" valign="middle" rowspan="1" colspan="1">2.56</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">Cotinine <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">0.30</td><td align="center" valign="middle" rowspan="1" colspan="1">0.72**</td><td align="center" valign="middle" rowspan="1" colspan="1">0.71**</td><td align="center" valign="middle" rowspan="1" colspan="1">2.00</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.17&#8211;0.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.41&#8211;2.20)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.39&#8211;1.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.42&#8211;9.40)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.40</td><td align="center" valign="middle" rowspan="1" colspan="1">2.37</td><td align="center" valign="middle" rowspan="1" colspan="1">6.67</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">3-OH cotinine <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.42**</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27**</td><td align="center" valign="middle" rowspan="1" colspan="1">1.20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.07&#8211;0.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.15&#8211;1.10)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.14&#8211;0.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.14&#8211;5.70)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.23</td><td align="center" valign="middle" rowspan="1" colspan="1">2.08</td><td align="center" valign="middle" rowspan="1" colspan="1">9.23</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">TNE <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">0.96</td><td align="center" valign="middle" rowspan="1" colspan="1">2.00**</td><td align="center" valign="middle" rowspan="1" colspan="1">2.00**</td><td align="center" valign="middle" rowspan="1" colspan="1">6.80</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.60&#8211;1.60)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.10&#8211;4.30)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.00&#8211;3.40)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.11&#8211;14.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.08</td><td align="center" valign="middle" rowspan="1" colspan="1">2.08</td><td align="center" valign="middle" rowspan="1" colspan="1">7.08</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">NNAL <break/>(pg/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">1.60</td><td align="center" valign="middle" rowspan="1" colspan="1">2.30*</td><td align="center" valign="middle" rowspan="1" colspan="1">2.50**</td><td align="center" valign="middle" rowspan="1" colspan="1">2.60</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.71&#8211;2.80)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.10&#8211;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.40&#8211;4.20)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.99&#8211;8.20)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.44</td><td align="center" valign="middle" rowspan="1" colspan="1">1.56</td><td align="center" valign="middle" rowspan="1" colspan="1">1.63</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">m<sup>7</sup>Gua <break/>(&#956;g/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">8.40</td><td align="center" valign="middle" rowspan="1" colspan="1">10.0*</td><td align="center" valign="middle" rowspan="1" colspan="1">10.0**</td><td align="center" valign="middle" rowspan="1" colspan="1">9.70</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(6.60&#8211;11.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(7.00&#8211;13.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(8.20&#8211;13.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(5.00&#8211;18.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.19</td><td align="center" valign="middle" rowspan="1" colspan="1">1.19</td><td align="center" valign="middle" rowspan="1" colspan="1">1.15</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">8-OHdG <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">3.8</td><td align="center" valign="middle" rowspan="1" colspan="1">3.9</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7</td><td align="center" valign="middle" rowspan="1" colspan="1">5.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(2.80&#8211;5.20)</td><td align="center" valign="middle" rowspan="1" colspan="1">(2.50&#8211;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">(2.60&#8211;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.90&#8211;11.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97</td><td align="center" valign="middle" rowspan="1" colspan="1">1.47</td></tr></tbody></table><table-wrap-foot><fn><p id="p021">*<italic toggle="yes">p</italic>&lt;0.05 and **<italic toggle="yes">p</italic>&lt;0.01 vs no SHS exposure group. <sup>&#167;</sup>(25% quartile&#8211;75% quartile)</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="portrait"><label>Table&#8196;2.</label><caption><p>Smoking restrictions and urinary biomarker levels of non-smoker at working place</p></caption><table frame="hsides" rules="groups"><col width="22" span="1"/><col width="15" span="1"/><col width="21" span="1"/><col width="21" span="1"/><col width="21" span="1"/><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Smoking restriction</th><th rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">No smoking inside <break/>the building</th><th align="center" valign="middle" rowspan="1" colspan="1">Designated <break/>smoking room</th><th align="center" valign="middle" rowspan="1" colspan="1">No restriction</th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="2" rowspan="1">Number of participants</td><td align="center" valign="middle" rowspan="1" colspan="1">244</td><td align="center" valign="middle" rowspan="1" colspan="1">193</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">TNE <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1.10</td><td align="center" valign="middle" rowspan="1" colspan="1">2.20**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile<sup>&#167;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">(0.68&#8211;1.70)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.65&#8211;1.70)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.98&#8211;8.90)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.10</td><td align="center" valign="middle" rowspan="1" colspan="1">2.20</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">NNAL <break/>(pg/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">2.10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.90</td><td align="center" valign="middle" rowspan="1" colspan="1">2.80**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.10&#8211;3.70)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.91&#8211;3.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">(2.10&#8211;7.60)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.90</td><td align="center" valign="middle" rowspan="1" colspan="1">1.33</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">m<sup>7</sup>Gua <break/>(&#956;g/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">9.00</td><td align="center" valign="middle" rowspan="1" colspan="1">8.90</td><td align="center" valign="middle" rowspan="1" colspan="1">10.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(6.90&#8211;12.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(6.90&#8211;11.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(6.70&#8211;12.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" rowspan="1" colspan="1">1.11</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">8-OHdG <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3.90</td><td align="center" valign="middle" rowspan="1" colspan="1">4.40</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(2.70&#8211;5.40)</td><td align="center" valign="middle" rowspan="1" colspan="1">(3.00&#8211;5.10)</td><td align="center" valign="middle" rowspan="1" colspan="1">(3.40&#8211;5.70)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" rowspan="1" colspan="1">1.10</td></tr></tbody></table><table-wrap-foot><fn><p id="p022">**<italic toggle="yes">p</italic>&lt;0.01 vs no SHS exposure group. <sup>&#167;</sup>(25% quartile&#8211;75% quartile)</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="portrait"><label>Table&#8196;3.</label><caption><p>Frequency of passive smoking and urinary biomarker levels at working place</p></caption><table frame="hsides" rules="groups"><col width="22" span="1"/><col width="14" span="1"/><col width="12.8" span="1"/><col width="12.8" span="1"/><col width="12.8" span="1"/><col width="12.8" span="1"/><col width="12.8" span="1"/><thead><tr><th align="left" valign="middle" colspan="2" rowspan="1">Frequency of passive smoking</th><th align="center" valign="middle" rowspan="1" colspan="1">0</th><th align="center" valign="middle" rowspan="1" colspan="1">1/month</th><th align="center" valign="middle" rowspan="1" colspan="1">1/week</th><th align="center" valign="middle" rowspan="1" colspan="1">Several/week</th><th align="center" valign="middle" rowspan="1" colspan="1">Daily</th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="2" rowspan="1">Number of participants</td><td align="center" valign="middle" rowspan="1" colspan="1">347</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">TNE <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1.20</td><td align="center" valign="middle" rowspan="1" colspan="1">1.10</td><td align="center" valign="middle" rowspan="1" colspan="1">2.20**</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile<sup>&#167;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">(0.66&#8211;1.80)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.65&#8211;1.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.70&#8211;1.90)</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.70&#8211;1.80)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.20&#8211;5.30)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1.20</td><td align="center" valign="middle" rowspan="1" colspan="1">1.10</td><td align="center" valign="middle" rowspan="1" colspan="1">2.20</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">NNAL <break/>(pg/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">1.80</td><td align="center" valign="middle" rowspan="1" colspan="1">2.50</td><td align="center" valign="middle" rowspan="1" colspan="1">2.30</td><td align="center" valign="middle" rowspan="1" colspan="1">2.10</td><td align="center" valign="middle" rowspan="1" colspan="1">3.30</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(0.91&#8211;3.60)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.60&#8211;3.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.60&#8211;3.20)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.30&#8211;2.90)</td><td align="center" valign="middle" rowspan="1" colspan="1">(1.80&#8211;6.30)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.38</td><td align="center" valign="middle" rowspan="1" colspan="1">1.28</td><td align="center" valign="middle" rowspan="1" colspan="1">1.17</td><td align="center" valign="middle" rowspan="1" colspan="1">1.83</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">m<sup>7</sup>Gua <break/>(&#956;g/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">9.10</td><td align="center" valign="middle" rowspan="1" colspan="1">9.00</td><td align="center" valign="middle" rowspan="1" colspan="1">8.60</td><td align="center" valign="middle" rowspan="1" colspan="1">8.60</td><td align="center" valign="middle" rowspan="1" colspan="1">8.30</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(6.90&#8211;12.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(7.20&#8211;12.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(6.20&#8211;10.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(5.50&#8211;10.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">(6.90&#8211;9.80)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" rowspan="1" colspan="1">0.95</td><td align="center" valign="middle" rowspan="1" colspan="1">0.95</td><td align="center" valign="middle" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1">8-OHdG <break/>(ng/mg creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">Median</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00</td><td align="center" valign="middle" rowspan="1" colspan="1">4.10</td><td align="center" valign="middle" rowspan="1" colspan="1">3.50</td><td align="center" valign="middle" rowspan="1" colspan="1">3.70</td><td align="center" valign="middle" rowspan="1" colspan="1">3.70</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Quartile</td><td align="center" valign="middle" rowspan="1" colspan="1">(3.00&#8211;5.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">(3.00&#8211;5.40)</td><td align="center" valign="middle" rowspan="1" colspan="1">(2.50&#8211;4.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">(2.90&#8211;4.40)</td><td align="center" valign="middle" rowspan="1" colspan="1">(2.50&#8211;5.10)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" rowspan="1" colspan="1">0.93</td><td align="center" valign="middle" rowspan="1" colspan="1">0.93</td></tr></tbody></table><table-wrap-foot><fn><p id="p023">**<italic toggle="yes">p</italic>&lt;0.01 vs no SHS exposure group. <sup>&#167;</sup>(25% quartile&#8211;75% quartile)</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>